Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -19.20
- Piotroski Score 3.00
- Grade Neutral
- Symbol (LUMO)
- Company Lumos Pharma, Inc.
- Price $4.33
- Changes Percentage (-0.35%)
- Change -$0.02
- Day Low $4.32
- Day High $4.35
- Year High $4.58
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $16.50
- High Stock Price Target $26.00
- Low Stock Price Target $7.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$4.58
- Trailing P/E Ratio -0.54
- Forward P/E Ratio -0.54
- P/E Growth -0.54
- Net Income $-34,034,000
Income Statement
Quarterly
Annual
Latest News of LUMO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Insider Selling: Akamai Technologies Inc's (AKAM) CTO Robert Blumofe Sells 3,000 Shares
Robert Blumofe, CTO of Akamai Technologies Inc, sold 3,000 shares of company stock, now owning 24,729 shares. Akamai specializes in cloud services for optimizing online content delivery....
By Yahoo! Finance | 5 months ago -
Rail firm FirstGroup plans to expand cut-price Lumo services
FirstGroup applies for more 'open access' services in response to government's aim to boost rail competition and lower fares. This move follows the success of its Lumo service between London and Edinb...
By The Guardian | 5 months ago -
T-Mobile to invest $950 million in venture with EQT to buy fiber optic network provider Lumos
(Reuters) - Wireless carrier T-Mobile US expects to invest about $950 million for a 50% stake in a joint venture with Swedish investment firm EQT's fund that will buy fiber optic network provider ...
By Reuters | 6 months ago
